2022年2期
刊物介紹
Cancer Biology & Medicine is a peer-reviewed open-access journal of Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. The journal quarterly provides innovative and significant information on biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The scope covers the following topics: ● Cancer epigenetics ● Cancer stem cell ● Improved in vivo and in vitro cancer models ● Cancer prevention and epidemiology ● Biomarkers for predicting drug response ● Mechanism of drug sensitivity and resistance ● New approaches for cancer detection and diagnosis ● Oncology clinical trials ● Targeted therapy ● Multidisciplinary treatment for cancer Author benefits: ● Easy online submission via Editorial Manager ● Efficient and professional peer-review by expert referees from around the world ● Rapid pre-print online publication ● No charge for publication and Open Access ● International visibility - the journal is available free online
Cancer Biology & Medicine
EDITORIAL
- Highlighted multi-modifications of enzymes: a novel succinylation mediated by histone acetyltransferase 1 in tumors
- A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer
- The emerging role of long noncoding RNA RMRP in cancer development and targeted therapy
REVIEW
ORIGINAL ARTICLE
- Efficacy of rigosertib,a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
- Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
- Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women